Clinical Trial Update: Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women [NA]

View source ↗

Summary

This completed clinical trial evaluated switching to intravenous zoledronic acid after teriparatide (Forteo) in postmenopausal osteoporosis; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Osteoporosis | NA | Status: COMPLETED | Results posted: 2011-01-14